MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis.

Salma Nur Azizah AzzahraNaufa Hanif Adam Hermawan

Published in: Asian Pacific journal of cancer prevention : APJCP (2022)

MDM2 may be a potential gene target of GA and the PI3K-AKT signaling may be a prospective mechanism for overcoming Tamoxifen resistance in breast cancer cells. Additional research is required to validate the findings of this study.

Keyphrases

breast cancer cells
bioinformatics analysis
copy number
genome wide
pet ct
estrogen receptor
genome wide identification
positive breast cancer
human health
dna methylation
risk assessment
young adults